Concord Biotech Limited (BOM: 543960)

Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	222,765	159,100	-	-	-	-
Enterprise Value	219,961	157,079	-	-	-	-
Last Close Price	2127.50	1513.48	-	-	-	-
PE Ratio	67.93	51.64	-	-	-	-
PS Ratio	19.58	15.65	-	-	-	-
PB Ratio	13.37	10.42	-	-	-	-
P/TBV Ratio	13.38	10.42	-	-	-	-
P/FCF Ratio	109.68	88.50	-	-	-	-
P/OCF Ratio	71.01	59.93	-	-	-	-
EV/Sales Ratio	20.26	15.45	-	-	-	-
EV/EBITDA Ratio	47.19	35.81	-	-	-	-
EV/EBIT Ratio	53.33	40.61	-	-	-	-
EV/FCF Ratio	113.45	87.37	-	-	-	-
Debt / Equity Ratio	0.00	0.01	0.02	0.06	0.09	0.07
Debt / EBITDA Ratio	0.01	0.02	0.09	0.22	0.27	0.24
Debt / FCF Ratio	0.02	0.05	0.31	1.19	-	-
Asset Turnover	0.65	0.63	0.60	0.57	0.58	-
Inventory Turnover	1.17	1.16	0.94	0.99	0.88	-
Quick Ratio	4.43	4.55	2.43	2.71	3.92	3.45
Current Ratio	6.60	6.30	3.79	4.08	5.74	4.68
Return on Equity (ROE)	22.27%	21.88%	20.06%	16.64%	26.55%	-
Return on Assets (ROA)	15.58%	15.04%	13.26%	11.47%	17.80%	-
Return on Capital (ROIC)	17.39%	16.92%	15.07%	12.70%	19.78%	-
Earnings Yield	1.47%	1.94%	-	-	-	-
FCF Yield	0.91%	1.13%	-	-	-	-
Dividend Yield	0.00%	0.58%	-	-	-	-
Payout Ratio	27.91%	23.19%	22.31%	40.31%	2.43%	47.63%
Total Shareholder Return	0.05%	0.58%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.